THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA AND THE MONOAMINE-OXIDASE INHIBITORS

被引:44
作者
BUCCI, L [1 ]
机构
[1] S MARIA PIETA HOSP, PIAZZA S MARIA PIETA 5, I-00135 ROMA, ITALY
关键词
D O I
10.1007/BF00690936
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:104 / 108
页数:5
相关论文
共 31 条
[2]   COMPARISON OF IPRONIAZID WITH OTHER AMINE OXIDASE INHIBITORS, INCLUDING W-1544, JB-516, RO 4-1018, AND RO 5-0700 [J].
BAILEY, SD ;
BUCCI, L ;
GOSLINE, E ;
KLINE, NS ;
PARK, IH ;
ROCHLIN, D ;
SAUNDERS, JC ;
VAISBERG, M .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1959, 80 (03) :652-668
[3]   DOPAMINE AND THE PATHO-PHYSIOLOGY OF DYSKINESIAS INDUCED BY ANTIPSYCHOTIC-DRUGS [J].
BALDESSARINI, RJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1980, 3 :23-41
[4]   LONG-TERM TREATMENT WITH L-DEPRENYL [J].
BIRKMAYER, W .
JOURNAL OF NEURAL TRANSMISSION, 1978, 43 (3-4) :239-244
[5]  
BLACKWELL B, 1964, LANCET, V1, P530
[6]  
BUCCI L, 1968, DIS NERV SYST, V29, P127
[7]  
BUCCI L, 1967, DIS NERV SYST, V28, P55
[8]  
BUCCI L, 1971, DIS NERV SYST, V32, P324
[9]  
BUCCI L, 1969, DIS NERV SYST, V30, P843
[10]  
CARENZI A, 1975, ARCH GEN PSYCHIAT, V32, P1056